Insider trades

Bobak R. Azamian, Chairman of Tarsus Pharmaceuticals TARS, has filed 0 purchases and 53 sales on the open market. Over the past 12 months that comes to a net sale of $3.5M. The latest trade was on 06/17.

Bobak R. Azamian

President/CEO and Board Chair
First filing
23/03/10
Trades
76 trades
Buys / sales
0 / 53
12-month net buying
−$3.5M
Last trade
06/17

Trading activity

Transactions

Trade type
TARS
Open-market sale10b5-1 plan06/1706/2210,000 sh2 trades$61.55avg.$615,488.26−1.2%
TARS
Open-market sale03/17–03/1903/1934,603 sh3 trades$68.34avg.$2,364,903.81−50.9%
TARS
Open-market sale10b5-1 plan25/12/2425/12/306,000 sh2 trades$82.51avg.$495,089.41−0.7%
Open-market sale10b5-1 plan25/09/2425/09/266,000 sh$55.37$332,220−0.7%
Open-market sale10b5-1 plan25/08/1125/08/136,000 sh$50.00$300,000−0.7%
Open-market sale25/03/2425/03/266,000 sh$50.00$300,000−0.7%
TARS
Open-market sale25/03/18–25/03/2025/03/2024,216 sh3 trades$48.03avg.$1,163,050.13−31.1%
Open-market sale24/03/1824/03/1910,415 sh$30.60$318,699−28.2%
Open-market sale10b5-1 plan23/12/2723/12/298,000 sh$20.22$161,760−1.0%
TARS
Open-market sale10b5-1 plan23/12/2023/12/2240,000 sh2 trades$20.27avg.$810,622.8−4.6%
TARS
Open-market sale10b5-1 plan23/11/1523/11/178,000 sh3 trades$18.37avg.$146,933.12−0.9%
Open-market sale10b5-1 plan23/10/1823/10/208,000 sh$13.24$105,920−0.9%
Open-market sale10b5-1 plan23/09/2023/09/228,000 sh$17.21$137,680−0.9%
Open-market sale10b5-1 plan23/08/2323/08/258,000 sh$17.23$137,840−0.9%
TARS
Open-market sale10b5-1 plan23/07/1923/07/21103,900 sh2 trades$20.01avg.$2,078,983.76−10.2%
Open-market sale10b5-1 plan23/07/1223/07/149,000 sh$17.35$156,150−0.9%
Open-market sale10b5-1 plan23/06/2123/06/238,000 sh$18.63$149,040−0.8%
Open-market sale10b5-1 plan23/06/1423/06/169,000 sh$18.58$167,220−0.9%
Open-market sale10b5-1 plan23/06/0823/06/123,100 sh$20.01$62,031−0.3%
Open-market sale10b5-1 plan23/05/1723/05/198,000 sh$15.90$127,200−0.8%